A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.
about
Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseCellular and molecular mechanisms of fibrosisThe enteric microbiome in hepatobiliary health and diseaseAlcohol and the IntestineClinical Advances in Fibrosis Progression of Chronic Hepatitis B and CMolecular prognostic prediction in liver cirrhosisIdentifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaLiver biopsy in modern clinical practice: a pediatric point-of-viewCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updateLiver fibrosis: mechanisms of immune-mediated liver injuryGene expression and hepatitis C virus infectionEndotoxin receptor CD14 gene variants and histological features in chronic HCV infectionMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesGenome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.Mechanisms of hepatic fibrogenesisCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseA brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosisEvolving therapies for liver fibrosis.Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2.A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cellsReversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling.Hepatic fibrosis.Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infectionToll-like receptor 4 and hepatic fibrogenesisFunctional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.Functional characterization of breast cancer using pathway profilesThe association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.Age and ethnicity in cirrhosis.A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population.Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Host genetics predict clinical deterioration in HCV-related cirrhosis.Cytokine production in patients with cirrhosis and TLR4 polymorphisms.
P2860
Q24594915-30305A8F-3F14-4BE4-A077-12DFD893F5BEQ24648892-80E9F352-D3CC-4510-82F0-57C754A5015CQ26777426-7FCCDBB0-5DEA-4539-B4A8-1F3F84BB6D77Q26778947-0CA08BDE-332C-4623-BD4C-700F296E58DFQ26781789-DB3E96EB-C64C-4841-A0DE-6917188CFF48Q26784251-C1C1188C-6D11-44E9-97C4-60B1C495E969Q26798033-F7EF988D-F5B8-4E26-9A7B-E6E7F5F7E62CQ26826919-E4AD406A-69F3-46CA-8D86-B81E2ED567D7Q26826920-29D0D7D1-3712-45B3-B28A-F578261265C0Q27027703-26D7F5BA-392C-492C-8A05-74DD65607BE8Q27027766-7C142821-90AC-4FA4-B210-6C5663AE5A22Q27488345-23439B06-A055-4447-B79E-9E564B0FE9D5Q27489395-E0672826-15CF-465E-8D7C-8EFF55BF5C35Q27692609-4C6B20DE-DB29-4697-A85E-A5BE5B597A7FQ28272678-8A7B2D3C-EF86-4BD0-89B6-18C960A8E6BFQ29417113-6CBD96B3-AE5C-485F-BB3F-B7217911456DQ29619336-93959E7C-E487-4BFA-BBE1-1327117D32DAQ30473375-97FA618C-C574-4450-8D0A-70C8E3EC1982Q30476922-4F201F94-B847-4617-811E-1FDF2B927E9CQ30496270-4C93292B-FC79-4F8C-8FB4-2495DCA452B9Q30539166-54B61702-ABDB-490E-8556-ED434B3591FDQ31138564-B991D6EE-A228-42A2-89BA-C304E7ADA4A2Q33350754-A9F54E80-3EBB-4BA7-9BB5-AC008F6E2DA1Q33354118-DF15DD07-CD0C-4435-9A15-86B855EB0F9DQ33648379-D2AE5B58-130B-4074-B471-36335E7F8EA2Q33731308-5F7D1A0F-4533-4E0F-BB3A-47A9BEAB5568Q33822409-B76213C2-B70D-4A88-B5ED-8062CC8D7BA3Q33904174-FEFF6EDA-2E24-4CB7-BC52-1DB521E94B54Q33904205-39B4E77E-A2FD-4A8B-A8A9-4E6181FEA2A1Q33905721-68D34469-4EB4-4A87-8B51-1F2DE31B248EQ33938566-A3706A87-9EBB-4261-9B39-FB8478647088Q33943907-0803C427-934C-40E3-BD2B-3D3240ED3FB0Q33962784-1C464890-41FC-4736-83C5-5D55E44BEF81Q34081261-5A9957E0-EC08-4DA9-8B5E-65B2B5548C37Q34231825-62725BCC-3E10-4D4D-BB2A-84C5EF563978Q34297774-A18DD45B-CAC1-4A9C-A6A9-8BF9532A5126Q34321742-40379E1A-B870-474D-B3D8-EEFB365948B1Q34647371-7162D57E-282B-409C-A2C8-065427BFCD30Q34689664-47510F77-4517-403E-86FA-4773A20710B2Q34696868-2B46CC9D-A65F-4538-8F27-2F91F85F6663
P2860
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@en
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@nl
type
label
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@en
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@nl
prefLabel
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@en
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@nl
P2093
P356
P1433
P1476
A 7 gene signature identifies ...... ents with chronic hepatitis C.
@en
P2093
Charles M Rowland
Diane U Leong
Hongjin Huang
John J Sninsky
Joseph J Catanese
Mitchell L Shiffman
Natalie Bzowej
Olivia T Abar
Ramasubbu Venkatesh
Ramsey C Cheung
P304
P356
10.1002/HEP.21695
P407
P577
2007-08-01T00:00:00Z